A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia
Clinical trial NCT01527305 · COMPLETED
Trial details
- NCT number
- NCT01527305
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-22
- Primary completion
- 2013-12-31
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.